Lawsuits in New Jersey involving injuries caused by the Stryker Rejuvenate and ABG II Modular Neck and Hip Stems hip implant components have been consolidated before one Circuit Court judge.
According to a recent decision from the New Jersey Supreme Court, lawsuits filed in any county in New Jersey will now be consolidated before Judge Brian R. Martinotti in Bergen County Superior Court as part of a Multicounty Litigation. There are already numerous lawsuits that have been filed in the state’s court system and any future claims against the recalled Stryker hip implant components will be transferred to that court.
Marinotti has scheduled an initial conference for Feb. 20 to begin proceedings. Consolidated lawsuits expedite and streamline the pre-trial portions of lawsuits against a single company or person. Decisions on admission of evidence and witnesses will be made at once and stand for any future trials. This process aims to reduce the likelihood a court decision will be appealed based on court technicalities.
Stryker recalled the Rejuvenate and ABG II hip implant component parts in July of last year after it was determined the modular neck junction part was prone to fretting and corrosion. These defects caused recipients of these devices to suffer severe pain, inflammation, and other injuries that required them to undergo revision or replacement surgeries to alleviate the problems caused by the defects.
Even though the recalled components are not entirely similar to a full metal-on-metal hip implant – the option that has plagued tens of thousands of recipients around the world – Stryker advised in the months following the recall that patients who’ve been fitted with the recalled devices undergo regular screenings to determine if they’re suffering from elevated metallic ion levels. This risk may be present in recipients who haven’t experienced the defect that prompted the recall last year. Elevated metallic ion levels are a hallmark complication caused by metal-on-metal hip implants and could cause recipients to suffer tissue and organ damage.
Stryker warned that some recipients of their recalled component parts have reported suffering from elevated metallic ion levels. The company has also retained a third-party claims operation to help recipients pay for out-of-pocket expenses caused by its defective and recalled hip implant component parts.
Recipients of defective Rejuvenate and ABG II components have reported suffering pain, inflammation, pseudotumors, necrosis of tissue, bone damage, and have experienced limited mobility.